Thomas R. Kuhn - 26 Dec 2024 Form 4/A - Amendment Insider Report for Anterix Inc. (ATEX)

Signature
s/ Gena L. Ashe, Attorney-in-Fact
Issuer symbol
ATEX
Transactions as of
26 Dec 2024
Net transactions value
$0
Form type
4/A - Amendment
Filing time
14 Jan 2025, 16:16:08 UTC
Date Of Original Report
30 Dec 2024
Previous filing
17 Dec 2024
Next filing
24 Jan 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Award $0 +7,108 $0.000000 7,108 26 Dec 2024 Common Stock 7,108 $31.25 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amended Form 4 is being filed to correct the previously reported grant amount of 61,804 option shares to the Reporting Person to reflect an actual grant of 7,108 option shares. The previously reported amount exceeded the compensation limit for non-employee directors set forth in the Issuer's 2023 Stock Plan by 54,696 option shares (the "Excess Option Shares"). The grant of the Excess Option Shares was null and void and has been rescinded by the Issuer.
F2 The option shares vest in full on December 26, 2027, subject to the Reporting Person's continued service with the Issuer through this date.